Volume 14, Issue 6, Pages (June 2001)

Slides:



Advertisements
Similar presentations
Volume 13, Issue 3, Pages (February 2004)
Advertisements

Volume 14, Issue 6, Pages (June 2001)
MHC class II/CD38/CD9: a lipid-raft–dependent signaling complex in human monocytes by Marie-Thérèse Zilber, Niclas Setterblad, Thierry Vasselon, Christelle.
Volume 9, Issue 5, Pages (November 1998)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Regulation of Mast Cell Survival by IgE
Volume 5, Issue 4, Pages (April 2004)
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
Volume 25, Issue 1, Pages (July 2006)
Volume 23, Issue 6, Pages (December 2005)
by Subburaj Ilangumaran, Anne Briol, and Daniel C. Hoessli
Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties by Frederick D. Goldman, Andrew L. Gilman,
Estela Jacinto, Guy Werlen, Michael Karin  Immunity 
Volume 87, Issue 7, Pages (December 1996)
Volume 18, Issue 1, Pages (January 2003)
Volume 25, Issue 1, Pages (July 2006)
Volume 8, Issue 16, Pages (July 1998)
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function by Alfonso Catalano, Paola Caprari, Simona Moretti, Monica.
Volume 10, Issue 6, Pages (December 2002)
BLNK Immunity Volume 9, Issue 1, Pages (July 1998)
Volume 26, Issue 1, Pages (January 2007)
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Volume 26, Issue 2, Pages (February 2007)
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Volume 19, Issue 6, Pages (September 2005)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 15, Issue 6, Pages (December 2001)
Volume 9, Issue 5, Pages (November 1998)
Lipotransin Molecular Cell
Volume 16, Issue 1, Pages (January 2006)
Silvia Bolland, Roger N Pearse, Tomohiro Kurosaki, Jeffrey V Ravetch 
Miriana Moran, M.Carrie Miceli  Immunity 
Volume 8, Issue 5, Pages (November 2001)
Volume 7, Issue 1, Pages (July 1997)
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Monika Raab, Antonio J.da Silva, Paul R. Findell, Christopher E. Rudd 
Volume 13, Issue 3, Pages (February 2004)
Volume 4, Issue 2, Pages (February 1996)
Regulation of Mast Cell Survival by IgE
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Volume 25, Issue 5, Pages (November 2006)
Volume 33, Issue 3, Pages (September 2010)
Christopher L. Kepley, PhDa, John C. Cambier, PhDb, Penelope A
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
Volume 15, Issue 4, Pages (August 2004)
Siqi Lin, Claudia Cicala, Andrew M Scharenberg, Jean-Pierre Kinet  Cell 
Volume 25, Issue 2, Pages (August 2006)
Volume 86, Issue 5, Pages (September 1996)
Volume 12, Issue 2, Pages (February 2000)
Volume 6, Issue 4, Pages (October 2000)
BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells
NGF Signaling from Clathrin-Coated Vesicles
Volume 8, Issue 14, Pages (July 1998)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Silva H Hanissian, Raif S Geha  Immunity 
LAT Links the Pre-BCR to Calcium Signaling
John M Schmitt, Philip J.S Stork  Molecular Cell 
Anu Cherukuri, Paul C. Cheng, Hae Won Sohn, Susan K. Pierce  Immunity 
David R. Riddell, Gary Christie, Ishrut Hussain, Colin Dingwall 
Volume 15, Issue 6, Pages (December 2001)
Volume 13, Issue 1, Pages (July 2000)
Volume 9, Issue 5, Pages (November 1998)
Volume 15, Issue 5, Pages (November 2001)
Volume 92, Issue 1, Pages (January 1998)
LAT Palmitoylation Immunity
Volume 23, Issue 2, Pages (August 2005)
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Volume 12, Issue 6, Pages (March 2002)
Volume 10, Issue 2, Pages (February 1999)
Epstein–Barr Virus Coopts Lipid Rafts to Block the Signaling and Antigen Transport Functions of the BCR  Michelle L Dykstra, Richard Longnecker, Susan.
Presentation transcript:

Volume 14, Issue 6, Pages 669-680 (June 2001) Involvement of SHP-1 Tyrosine Phosphatase in TCR-Mediated Signaling Pathways in Lipid Rafts  Atsushi Kosugi, Junko Sakakura, Koubun Yasuda, Masato Ogata, Toshiyuki Hamaoka  Immunity  Volume 14, Issue 6, Pages 669-680 (June 2001) DOI: 10.1016/S1074-7613(01)00146-7

Figure 1 Characterization of the Chimeric LAT/SHP-1 Molecules Used in This Study (A) Schematic representations of the chimeric LAT/SHP-1 molecules. LAT/SHP-1 chimeras were constructed by attaching Flag-tagged SHP-1 deleted of two SH2 domains [SHP-1(ΔSH2)] to the extracellular and transmembrane domains of mouse LAT. The amino acids of LAT (1–36) and those of SHP-1 (205–595) included in the constructs are indicated. Mutated amino acids are shown for each construct. (B) 293T cells transiently transfected with the described constructs were solubilized with lysis buffer, and the lysates were immunoprecipitated and immunoblotted with anti-Flag mAb (M2). (C) Dephosphorylation of p-nitrophenyl phosphate (p-NPP) by anti-Flag immunoprecipitates obtained from the same transfectants as shown in (B). p-NP production was calculated from absorbance measurement at 414 nm. The nonenzymatic hydrolysis of the substrate, measured by the optical density without the immunoprecipitates, was used as a negative control Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 2 Subcellular Localization of LAT/SHP-1 Expressed in Jurkat-Derived Transfectants (A) Jurkat cells and transfectants were disrupted by homogenization in hypotonic buffer and then separated into soluble cytosolic (S) and membrane pellet (P) fractions by ultracentrifugation. After subcellular fractionation, equal aliquots from the two fractions were immunoprecipitated and immunoblotted with anti-SHP-1 mAb. Because LAT/SHP-1 does not contain two SH2 domains, it migrates faster than endogenous SHP-1 on SDS-PAGE. An open arrowhead indicates endogenous SHP-1, whereas closed arrowheads indicate the chimeric LAT/SHP-1 molecules. (B) Jurkat-derived transfectants were lysed with MBS containing 1% TX-100, and the lysates were subjected to equilibrium gradient centrifugation. An aliquot of each fraction was electrophoresed under reducing conditions and immunoblotted with anti-Flag mAb. (C) Localization of endogenous LAT and CD45 in rafts from Jurkat or Jurkat-derived transfectants was analyzed by sucrose density gradients. Each aliquot from fractions 4 and 5 (the raft fractions; Raft) or from fractions 11 and 12 (the TX-soluble fractions; TXS) was combined, electrophoresed, and tested for their protein levels of LAT and CD45 by immunoblotting analysis Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 3 CD69 Expression and Transcriptional Activation of NFAT and AP-1 Reporter Genes in Jurkat-Derived Transfectants Expressing LAT/SHP-1 (A) CD69 expression. Cells were stimulated either with immobilized OKT3 or with 10 ng/ml of PMA for 16 hr. The cells were stained with FITC-conjugated anti-CD69 mAb and analyzed by flow cytometry. Dotted lines and solid lines represent cells without and with staining, respectively. (B) CD69 expression after stimulation with the indicated concentration of OKT3 was analyzed. The percentage of cells which were CD69 positive was determined using histograms without staining to set the background levels. (C) CD69 expression after T cell activation was analyzed in three different transfectants expressing the chimeric constructs indicated. Nonstimulated cells were used as controls. (D and E) Activation of NFAT- and AP-1-luciferase reporter genes. Cells were transfected either with NFAT-luc (500 ng) and pRL-TK (50 ng), using DMRIE-C, or with AP-1-luc (20 μg) and pRL-TK (1 μg), using the electroporation method. After 1 day, cells were stimulated with immobilized OKT3 plus PMA or with ionomycin plus PMA for 6–8 hr. The graph shows the average and standard error from three independent experiments Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 4 Tyrosine Phosphorylation of Cellular Proteins and Ca2+ Response in Jurkat-Derived Transfectants Expressing LAT/SHP-1 (A) Tyrosine phosphorylation of cellular proteins after TCR cross-linking. Cells were either left untreated (−) or were stimulated with OKT3 for 2 min (+) prior to the isolation of whole-cell lysates. Equivalent amounts of lysates were then separated by SDS-PAGE and analyzed by immunoblotting using anti-phosphotyrosine (PY) mAb. Molecular sizes (kDa) are shown on the left. (B) Cells were loaded with Fura-2AM, and Ca2+ mobilization in response to cross-linking of OKT3 was determined using a fluorescence spectrophotometer (Hitachi F-3000) with excitation at 340 nm and emission at 510 nm. Closed arrowheads represent the addition of OKT3 mAb. (C) Tyrosine phosphorylation of cellular proteins in the raft fractions after TCR cross-linking. Cells were either left untreated (−) or were stimulated with OKT3 for 5 min (+) prior to the isolation of the raft fractions. Equivalent amounts from the raft fractions were then separated by SDS-PAGE and analyzed by immunoblotting with anti-PY (top) and with anti-Lck to ensure equal loading of lanes (bottom). Tyrosine phosphorylation of proteins likely to be Cbp/PAG and LAT is indicated Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 5 Tyrosine Phosphorylation of TCRζ and ZAP-70 and the Kinase Activity of Lck in Jurkat-Derived Transfectants Expressing LAT/SHP-1 (A and B) Cells were stimulated with OKT3 for the times indicated. Cell lysates were immunoprecipitated with either anti-TCRζ (A) or anti-ZAP-70 (B) Ab, and immunoprecipitates were analyzed by immunoblotting with anti-PY Ab and Abs specific for the immunoprecipitated protein. (C) In vitro kinase assays of Lck from the raft and the TXS fractions. Cells were either left untreated (−) or were stimulated with OKT3 for 5 min (+) prior to the isolation of the raft and the TXS fractions. In vitro kinase assays were performed using Lck from each membrane fraction after immunoprecipitation with anti-Lck mAb. Enolase was used as an exogenous substrate. The amount of Lck in each fraction was measured by immunoblotting Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 6 LAT Activation and Downstream Signaling Events after TCR Stimulation in Jurkat-Derived Transfectants Expressing LAT/SHP-1 (A, C, and D) Tyrosine phosphorylation of LAT (A), PLCγ1 (C), and ERK (D) after TCR stimulation. Cells were stimulated with OKT3 for the times indicated. Cell lysates were immunoprecipitated with either anti-LAT or anti-PLCγ1 Ab, and immunoprecipitates were analyzed by immunoblotting with anti-PY Ab and Abs specific for the immunoprecipitated protein. Tyrosine phosphorylation and the total amount of ERK was analyzed by anti-phospho-ERK and anti-ERK blotting, respectively, using whole-cell lysates. (B) Association of LAT with various signaling molecules. Cell lysates were immunoprecipitated with anti-LAT Ab, and the association of LAT with the various signaling molecules was determined by blotting with specific antibodies. The total amounts of these proteins were comparable between mock and LAT/SHP-1 transfectants (data not shown). (E) IP3 generation. Cells were stimulated with OKT3 for the times indicated. The amount of IP3 was determined based on competition between [3H]IP3 and unlabeled IP3, using the IP3 [3H] assay system (Amersham). The graph shows the average and standard error from two independent experiments. (F) Ras activation. Cells were stimulated with OKT3 for the times indicated. Ras activation was determined by the amount of Ras-GTP in cell lysates that was bound with Raf-1, using the Ras activation assay kit (Upstate Biotechnology) Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)

Figure 7 Effect of Raft-Targeted SHP-2 on TCR Signaling and Increased Recruitment to Rafts and Association with LAT of Endogenous SHP-1 after TCR Stimulation (A and B) Jurkat-derived transfectants expressing LAT/SHP-1 or LAT/SHP-2 were stimulated with OKT3, and CD69 expression (A) and tyrosine phosphorylation of ERK (B) were analyzed as described in Figures 3A and 6D, respectively. (C) Jurkat cells were stimulated with OKT3 for the times indicated. Endogenous SHP-1 and SHP-2 in the raft fraction were detected by immunoblotting analysis using specific antibodies. The amount of Lck in each lane was measured by immunoblotting with anti-Lck to ensure equal loading. (D) The association of endogenous SHP-1 with LAT was detected by immunoprecipitation with anti-LAT Ab followed by blotting with anti-SHP-1 Ab. (E) Jurkat cells were either left untreated (−) or were stimulated with OKT3 for 30 min (+) prior to the isolation of the raft and the TXS fractions. The association of SHP-1 with LAT in each membrane fraction was detected by immunoprecipitation with anti-LAT Ab, followed by blotting with anti-SHP-1 Ab. The amounts of Lck and CD45 in each fraction were also measured by immunoblotting, using specific antibodies to confirm the preparation of rafts Immunity 2001 14, 669-680DOI: (10.1016/S1074-7613(01)00146-7)